Arcus Biosciences, Inc.

RCUS

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001724521

SEC filings (opens in a new tab)

In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Arcus Biosciences, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of RCUS: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Of which not filed for Q2 2023	Q2 2023	Change
Holders	180	1	181	+2
Shares	55.4M	14.1K	54.7M	−719.2K (−1.3%)
Value	$1.01B	$256.7K	$1.11B	+$98.2M (+9.7%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Arcus Biosciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to RCUS in Q2 2023
Institution	Shares	Value	% of portfolio
Balyasny Asset Management LLC	1,866,716	$37.9M	0.11%
Logos Global Management LP	750,000	$15.2M	2.10%
Point72 Asset Management, L.P.	709,641	$14.4M	0.05%
Woodline Partners LP	248,000	$5.04M	0.06%
Group One Trading, L.P.	96,466	$1.96M	0.08%
Jump Financial, LLC	63,921	$1.30M	0.05%
Millennium Management LLC	55,345	$1.12M	0.00%
Moore Capital Management, LP	40,000	$812.4K	0.02%
Cresset Asset Management, LLC	35,133	$713.6K	0.01%
Centiva Capital, LP	34,984	$710.5K	0.04%
Duality Advisers, LP	29,050	$590.0K	0.07%
Occudo Quantitative Strategies LP	28,783	$584.6K	0.06%
XTX Topco Ltd	16,463	$334.4K	0.06%
Teza Capital Management LLC	10,157	$206.3K	0.03%
D. E. Shaw & Co., Inc.	9,995	$203.0K	0.00%
Exchange Traded Concepts, LLC	6,975	$141.7K	0.00%
Amundi	6,713	$137.2K	0.00%
Healthcare of Ontario Pension Plan Trust Fund	5,000	$101.5K	0.00%
Focused Wealth Management, Inc	3,000	$60.9K	0.01%
Quantbot Technologies LP	300	$6.09K	0.00%
Fifth Third Bancorp	204	$4.14K	0.00%
Coppell Advisory Solutions LLC	200	$3.94K	0.00%
Bessemer Group Inc	63	$1.00K	0.00%
Impact Partnership Wealth, LLC	37	$751	0.00%
SJS Investment Consulting Inc.	6	$122	0.00%
Comerica Bank	841	$0	0.00%

Sold out (24)

Institutions that held Arcus Biosciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of RCUS in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Verition Fund Management LLC	357,986	$6.53M
AQR Capital Management LLC	221,257	$4.04M
Tang Capital Management LLC	147,920	$2.70M
Man Group plc	–	$988.0K
PDT Partners, LLC	51,925	$947.1K
Tejara Capital Ltd	50,000	$912.0K
1492 Capital Management LLC	30,733	$560.6K
Vident Investment Advisory, LLC	23,276	$424.6K
STRS Ohio	22,600	$412.0K
Gsa Capital Partners LLP	20,886	$381.0K
Trexquant Investment LP	18,827	$343.4K
NinePointTwo Capital	15,916	$290.0K
First Trust Advisors LP	15,845	$289.0K
Worth Venture Partners, LLC	12,700	$231.6K
SG Americas Securities, LLC	12,184	$222.0K
Hancock Whitney Corp	11,945	$218.0K
Susquehanna Fundamental Investments, LLC	11,180	$203.9K
Caption Management, LLC	9,000	$164.2K
State of Wyoming	3,104	$56.6K
Acadian Asset Management LLC	1,444	$26.0K
Bogart Wealth, LLC	26	$474
Schubert & Co	11	$201
TCI Wealth Advisors, Inc.	2	$37
Steward Financial Group LLC	13	$0

Not filed for Q2 2023 yet (1)

Institutions that held Arcus Biosciences, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCUS in Q1 2023 that haven't filed for Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
ETF Managers Group, LLC	14,076	$256.7K